Biosimilar drugs.

Authors: Senator Brandt Hershman, Senator Ronald Grooms

Co-authors: Senator Jean Breaux

Sponsors: Representative Edward Clere

Co-Sponsors: Representative Mara Candelaria Reardon, Representative Steven Davisson, Representative Robin Shackleford


Allows a pharmacist to substitute an interchangeable biosimilar product for a prescribed biological product if certain conditions are met. Requires a pharmacist to record in a certain manner the name and manufacturer of a biologic product that the pharmacist is dispensing not later than ten days after dispensing the biologic product. Requires the board of pharmacy to maintain a link on the board's website to the current list of all biological products that are determined by the United States Food and Drug Administration to be interchangeable with a specific reference biological product. Allows the board of pharmacy to adopt rules. Provides that a written or electronic prescription for a biological product must comply with the existing prescription form requirements. (The introduced version of this bill was prepared by the health finance commission.)